Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy

Primary tabs

field_vote: 
8
Average: 8 (2 votes)
Disease(s): 
Therapeutic intervention: 
Therapeutic Substance(s): 
Publication type: 

1.

Photochem Photobiol Sci. 2010 Oct 26. [Epub ahead of print]

Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy.

Kwitniewski M, Moan J, Juzeniene A.

Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, 0310, Norway. kwitniewski@gumed.edu.pl.

Abstract

For the first time we present data showing that metabolic targeted therapy with dichloroacetate (DCA) may improve the outcome of photodynamic therapy. This treatment modality can be easily introduced into clinical practice guidelines.

PMID: 20978658 [PubMed - as supplied by publisher]